A carregar...
Clinical Benefit of Nanoparticle Albumin-Bound-Paclitaxel in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma Resistant to Cremophor-Based Paclitaxel or Docetaxel
BACKGROUND: The clinical benefit of nab-paclitaxel monotherapy for recurrent/metastatic head and neck squamous cell carcinoma (RM-HNSCC) that progressed on other taxanes (cremophor-based paclitaxel or docetaxel) is unknown. METHODS: A retrospective analysis of patients treated at a single institutio...
Na minha lista:
| Publicado no: | Med Oncol |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6754095/ https://ncbi.nlm.nih.gov/pubmed/28078561 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12032-017-0884-7 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|